Atovaquone Oral Suspension, USP 750 mg/5 mL, 210 mL bottle, Rx only, Distributed by: Bionpharma Inc., Princeton, NJ 08540, NDC # 69452-252-87.
Published October 23, 2024 · Recall initiated: September 17, 2024
Summary
FDA records drug Class I recall D-0012-2025, published October 23, 2024 and initiated September 17, 2024. Recalling firm: Bionpharma Inc.; Status: Terminated; Reported quantity: 1,980 bottles; Lot: Lot # 2310083, Exp. 09/30/2025. Class I means a reasonable probability of serious adverse health consequences or death.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Microbial Contamination of a Non-sterile Product: The product was found to be contaminated with Cohnella bacteria.
What to do
Voluntary: Firm initiated · Press Release
Get an email if ATOVAQUONE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- ATOVAQUONE
- Manufacturer
- Bionpharma Inc.
- Distributor
- Nationwide in the U.S.A.
- UPC
- 0369452252871
- Lot
- Lot # 2310083, Exp. 09/30/2025
- Risk classification
- Class I
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDADapsone Gel 7.5%, 60 gram pump, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India,October 23, 2024
- FDAFirst Aid Antiseptic Ointment, Povidone Iodine USP 10%, Inactive Ingredients: mineral oil, petrolatum. NET Wt.October 23, 2024
- FDACisplatin Injection, 100mg/100mL (1mg/mL), For Intravenous Use, 100 mL Multiple Dose Vial, Rx Only,October 23, 2024
- FDARum Raisin Ice Cream, packaged in paper and plastic containers in sizes 3 Gallons, half gallons, and quarts.October 23, 2024
- FDADuloxetine Delayed-Release Capsules, USP, 20mg, Rx Only, 500-count bottles, Mfr. by: Towa PharmaceuticalOctober 23, 2024
- FDAAtovaquone Oral Suspension USP, 750 mg/5 mL, Packaged in 210 mL bottle, Manufactured for: CamberMay 17, 2023
Questions about this recall
Was Atovaquone Oral Suspension, USP 750 mg/5 mL, 210 mL bottle, Rx only, Distributed by: Bionpharma Inc., Princeton, NJ 08540, NDC # 69452-252-87. recalled?
Yes. FDA published recall D-0012-2025 on October 23, 2024. Reported hazard: Microbial Contamination of a Non-sterile Product: The product was found to be contaminated with Cohnella bacteria.
What should I do if I have this product?
Voluntary: Firm initiated · Press Release
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: ATOVAQUONE. UPC: 0369452252871.